封面
市場調查報告書
商品編碼
1413013

次要大麻素市場:按產品、按應用分類 - 全球預測 2024-2030

Minor Cannabinoids Market by Products (Cannabichromene, Cannabigerol, Cannabigerolic Acid), Application (Cancer, Inflammation, Neurological Disorders) - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年小大麻素市場規模預計為176.3億美元,預計2024年將達到187.9億美元,2030年將達到301.3億美元,複合年成長率為7.95%。

次要大麻素的全球市場

主要市場統計
基準年[2023] 176.3億美元
預測年份 [2024] 187.9億美元
預測年份 [2030] 301.3億美元
複合年成長率(%) 7.95%
次要大麻素市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣對於評估次要大麻素市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市場佔有率分析

市場佔有率分析是一種綜合工具,可以對次要大麻素市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略,從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解:

1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。

3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題:

1-次要大麻素市場的市場規模和預測是多少?

2-小大麻素市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?

3-次要大麻素市場的技術趨勢和法律規範是什麼?

4-次要大麻素市場主要供應商的市場佔有率為何?

5-進入次要大麻素市場的適當型態和策略手段是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 次要大麻素的醫療益處
      • 大麻合法化取得進展
      • 新型微大麻素食品和飲料產品簡介
    • 抑制因素
      • 次要大麻素成本高昂
    • 機會
      • 繼續研究和開發次要大麻素
      • 資金和投資使更好的產品商業化
    • 任務
      • 關於次要大麻素的嚴格規定
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 次要大麻素市場:依產品

  • 大麻色烯
  • 大麻醇
  • 大麻二酚酸
  • 大麻酚
  • 四氫大麻二酚

第7章 小型大麻素市場:依應用分類

  • 癌症
  • 發炎
  • 神經系統疾病
  • 疼痛管理

第8章美洲的小型大麻素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太次要大麻素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的小型大麻素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析:主要企業
  • 主要企業競爭情境分析

第12章競爭產品組合

  • 主要公司簡介
    • Fresh Bros Hemp Company
    • GenCanna
    • Global Cannabinoids
    • Laurelcrest
    • Mile High labs International
    • Pacific Roots, LLC
    • Rhizo Sciences
    • Sanobiotec
    • Zero Point Extraction, LLC
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-3A2E844FF0B1

[193 Pages Report] The Minor Cannabinoids Market size was estimated at USD 17.63 billion in 2023 and expected to reach USD 18.79 billion in 2024, at a CAGR 7.95% to reach USD 30.13 billion by 2030.

Global Minor Cannabinoids Market

KEY MARKET STATISTICS
Base Year [2023] USD 17.63 billion
Estimated Year [2024] USD 18.79 billion
Forecast Year [2030] USD 30.13 billion
CAGR (%) 7.95%
Minor Cannabinoids Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Minor Cannabinoids Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Minor Cannabinoids Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Minor Cannabinoids Market, highlighting leading vendors and their innovative profiles. These include Fresh Bros Hemp Company, GenCanna, Global Cannabinoids, Laurelcrest, Mile High labs International, Pacific Roots, LLC, Rhizo Sciences, Sanobiotec, and Zero Point Extraction, LLC.

Market Segmentation & Coverage

This research report categorizes the Minor Cannabinoids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Products
    • Cannabichromene
    • Cannabigerol
    • Cannabigerolic Acid
    • Cannabinol
    • Tetrahydrocannabivarin
  • Application
    • Cancer
    • Inflammation
    • Neurological Disorders
    • Pain Management
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Minor Cannabinoids Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Minor Cannabinoids Market?

3. What are the technology trends and regulatory frameworks in the Minor Cannabinoids Market?

4. What is the market share of the leading vendors in the Minor Cannabinoids Market?

5. Which modes and strategic moves are suitable for entering the Minor Cannabinoids Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Minor Cannabinoids Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Medical benefits of minor cannabinoids
      • 5.1.1.2. Increasing legalization of cannabinoids
      • 5.1.1.3. Introduction of new minor-cannabinoid food & beverage products
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of minor cannabinoids
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D of minor cannabinoids
      • 5.1.3.2. Funding and investments for better product commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations regarding minor cannabinoids
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Minor Cannabinoids Market, by Products

  • 6.1. Introduction
  • 6.2. Cannabichromene
  • 6.3. Cannabigerol
  • 6.4. Cannabigerolic Acid
  • 6.5. Cannabinol
  • 6.6. Tetrahydrocannabivarin

7. Minor Cannabinoids Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Inflammation
  • 7.4. Neurological Disorders
  • 7.5. Pain Management

8. Americas Minor Cannabinoids Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Minor Cannabinoids Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Minor Cannabinoids Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Fresh Bros Hemp Company
    • 12.1.2. GenCanna
    • 12.1.3. Global Cannabinoids
    • 12.1.4. Laurelcrest
    • 12.1.5. Mile High labs International
    • 12.1.6. Pacific Roots, LLC
    • 12.1.7. Rhizo Sciences
    • 12.1.8. Sanobiotec
    • 12.1.9. Zero Point Extraction, LLC
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. MINOR CANNABINOIDS MARKET RESEARCH PROCESS
  • FIGURE 2. MINOR CANNABINOIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. MINOR CANNABINOIDS MARKET DYNAMICS
  • FIGURE 7. MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 8. MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. MINOR CANNABINOIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 6. MINOR CANNABINOIDS MARKET SIZE, BY CANNABICHROMENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROLIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. MINOR CANNABINOIDS MARKET SIZE, BY CANNABINOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MINOR CANNABINOIDS MARKET SIZE, BY TETRAHYDROCANNABIVARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. MINOR CANNABINOIDS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MINOR CANNABINOIDS MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MINOR CANNABINOIDS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MINOR CANNABINOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 103. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. MINOR CANNABINOIDS MARKET LICENSE & PRICING